Literature DB >> 3171581

Effect of dexamethasone on transport of alpha-aminoisobutyric acid and sucrose across the blood-brain barrier.

Y Z Ziylan1, J M LeFauconnier, G Bernard, J M Bourre.   

Abstract

The effect of glucocorticoids on the blood-brain barrier (BBB) was studied in rats following a single injection or 3 days of dexamethasone administration. Tracers with a low permeability across the intact endothelium, [14C]sucrose and alpha-[3H]aminoisobutyric acid ([3H]AIB), were simultaneously injected intravenously in untreated rats or in rats treated with dexamethasone. Unidirectional blood-to-brain transfer constants (Ki) in 14 regions of the rat brain were determined. In regions of control brain, average Ki values for AIB and sucrose were approximately 0.0020 and 0.00060 ml g-1 min-1, respectively. The lowest transfer constants were found in caudate nucleus, hippocampus, white matter, and cerebellum. In dexamethasone-treated animals, Ki values for both sucrose and AIB markedly decreased by 30-50% in almost all brain regions. These results indicate that a single injection or 3 days of treatment with dexamethasone causes an apparent reduction in the normal BBB permeability, and dexamethasone may greatly interfere with drug delivery into brain. These observations may have an importance for the administration of drugs in brain disease in the presence of steroids.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3171581     DOI: 10.1111/j.1471-4159.1988.tb01094.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Effects of hepatic ischemia-reperfusion injury on the blood-brain barrier permeability to [14C] and [13C]sucrose.

Authors:  Mohammad K Miah; Ulrich Bickel; Reza Mehvar
Journal:  Metab Brain Dis       Date:  2017-08-04       Impact factor: 3.584

2.  Stress does not increase blood-brain barrier permeability in mice.

Authors:  Martin Roszkowski; Johannes Bohacek
Journal:  J Cereb Blood Flow Metab       Date:  2016-05-04       Impact factor: 6.200

3.  The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin.

Authors:  Anargyros Xenocostas; Wing K Cheung; Francis Farrell; Cindy Zakszewski; Marian Kelley; Andrzej Lutynski; Michael Crump; Jeffrey H Lipton; Thomas L Kiss; Catherine Y Lau; Hans A Messner
Journal:  Eur J Clin Pharmacol       Date:  2005-03-18       Impact factor: 2.953

4.  Steroids decrease uptake of carboplatin in rat gliomas--uptake improved by intracarotid infusion of bradykinin analog, RMP-7.

Authors:  K Matsukado; S Nakano; R T Bartus; K L Black
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

5.  Linoleic acid passage through the blood-brain barrier and a possible effect of age.

Authors:  L Avellini; L Terracina; A Gaiti
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

6.  Intrathecal corticoids in permanent focal cerebral ischemia in rats. Part I: a new therapeutic approach in the acute phase.

Authors:  Sophia L Goericke; Tobias Engelhorn; Michael Forsting; Ulrich Speck; Stefan Maderwald; Mark E Ladd; Arnd Doerfler
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

7.  The effects of dexamethasone on experimental brain tumors: I. Transcapillary transport and blood flow in RG-2 rat gliomas.

Authors:  P Molnar; G D Lapin; D R Groothuis
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

8.  Enhanced delivery of carboplatin into brain tumours with intravenous Cereport (RMP-7): dramatic differences and insight gained from dosing parameters.

Authors:  D F Emerich; P Snodgrass; R Dean; M Agostino; B Hasler; M Pink; H Xiong; B S Kim; R T Bartus
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

9.  Neurovascular damage in experimental allergic encephalomyelitis: a target for pharmacological control.

Authors:  C Bolton
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.